We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Lexology logo
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 2,662

The bottom ten the worst prescription drugmedical device decisions of 2012

  • Reed Smith LLP
  • -
  • USA
  • -
  • December 21 2012

Do we have to? That depends on whether we mean "must" or should." There's relatively little that's really a "must," but quite a bit that's a strong

Medicare physician paymentDMEPOS bidding delay legislation enacted

  • Reed Smith LLP
  • -
  • USA
  • -
  • July 16 2008

On July 15, 2008, the House and Senate overrode the President's veto of H.R. 6331, the "Medicare Improvements for Patients and Providers Act of 2008.”

The “Medicare Improvements for Patients and Providers Act of 2008”: delay and reform of the Medicare DMEPOS competitive bidding program

  • Reed Smith LLP
  • -
  • USA
  • -
  • July 28 2008

On July 15, 2008, the House and Senate overrode President Bush’s veto of H.R. 6331, the “Medicare Improvements for Patients and Providers Act of 2008” (“MIPPA”

FDA issues public health notification about potential risks associated with change in date for Daylight Savings Time

  • Reed Smith LLP
  • -
  • USA
  • -
  • March 7 2007

With the onset of Daylight Savings Time (“DST”) on March 11, 2007, the federal Food and Drug Administration (“FDA”) has issued a public health notification about risks that might be associated with changing the clock

Medicare Part D March 1, 2007 CMS reporting deadline

  • Reed Smith LLP
  • -
  • USA
  • -
  • February 19 2007

The Medicare Prescription Drug, Improvement, and Modernization Act of 2003 requires group health plans ("GHPs") that offer prescription drug coverage to Medicare-eligible individuals, to disclose to the Centers for Medicare and Medicaid Services (CMS), at least annually, whether the GHPs' prescription drug coverage is or is not creditable

Medicare physician paymentDMEPOS bidding delay legislation approved

  • Reed Smith LLP
  • -
  • USA
  • -
  • July 11 2008

On July 9, 2008, the Senate overwhelmingly approved H.R. 6331 "Medicare Improvements for Patients and Providers Act of 2008,” which rescinds a 10.6 cut in physician payments and delays a controversial medical equipment competitive bidding program, both of which went into effect July 1, 2008, and makes numerous other Medicare and Medicaid policy changes

Department of Health and Human Services enters into first settlement agreement for HIPAA violations

  • Reed Smith LLP
  • -
  • USA
  • -
  • July 24 2008

On July 15, 2008, the U.S. Department of Health and Human Services (“HHS”) entered into a Resolution Agreement with Providence Health & Services (“Providence”) that included a monetary settlement to address potential privacy and security violations of the Health Insurance Portability and Accountability Act of 1996 (“HIPAA”

OFT report recommends reform to UK drug pricing scheme

  • Reed Smith LLP
  • -
  • United Kingdom
  • -
  • March 7 2007

The OFT has recommended that the Pharmaceutical Price Regulation Scheme (PPRS) should be reformed, to deliver better value for money from NHS drug spend and to focus business investment on drugs that have the greatest benefits for patients

IRS issues regulations to implement ACA medical device tax

  • Reed Smith LLP
  • -
  • USA
  • -
  • December 20 2012

On December 7, 2012, the IRS published final regulations that provide guidance on the 2.3 excise tax imposed on any sale occurring after December 31, 2012

Congressional hearings

  • Reed Smith LLP
  • -
  • USA
  • -
  • July 29 2008

Congressional committees have held numerous hearings on health policy issues recently